Dr Martens has reported £322 million (~$421 million) in H1 FY26 revenue, up 0.8 per cent CC, with stronger wholesale and 6 per cent growth in full-price DTC sales.
The Americas led with 6 per cent growth, while EMEA fell 3 per cent and APAC rose 2 per cent.
CEO Ije Nwokorie highlighted early progress on the consumer-first strategy and continued cost discipline despite a cautious market.
Source link
